Skip to main content
SpringerLink
Log in

Recombinant human activated protein C in experimental models of acute lung injury: the timing is critical!

  • Editorial
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Liaw PC (2004) Endogenous protein C activation in patients with severe sepsis. Crit Care Med 32:S214–S218

    Article  PubMed  CAS  Google Scholar 

  2. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709

    Article  PubMed  CAS  Google Scholar 

  3. Richard J-C, Bregeon F, Leray V, Le Bars D, Costes N, Tourvieille C, Lavenne F, Devouassoux-Shisheboran M, Gimenez G, Guerin C (2007) Effect of activated protein C on pulmonary blood flow and cytokine production in experimental acute lung injury. Intensive Care Med DOI 10.1007/s00134-007-0782-0

  4. Schuster DP (1994) ARDS: clinical lessons from the oleic acid model of acute lung injury. Am J Respir Crit Care Med 149:245–260

    PubMed  CAS  Google Scholar 

  5. Rosenthal C, Caronia C, Quinn C, Lugo N, Sagy M (1998) A comparison among animal models of acute lung injury. Crit Care Med 26:912–916

    Article  PubMed  CAS  Google Scholar 

  6. Hill LL, Chen DL, Kozlowski J, Schuster DP (2004) Neutrophils and neutrophil products do not mediate pulmonary hemodynamic effects of endotoxin on oleic acid-induced lung injury. Anesth Analg 98:452–457

    Article  PubMed  CAS  Google Scholar 

  7. Gust R, Kozlowski J, Stephenson AH, Schuster DP (1998) Synergistic hemodynamic effects of low-dose endotoxin and acute lung injury. Am J Respir Crit Care Med 157:1919–1926

    PubMed  CAS  Google Scholar 

  8. Chen DL, Schuster DP (2004) Positron emission tomography with [18F]fluorodeoxyglucose to evaluate neutrophil kinetics during acute lung injury. Am J Physiol Lung Cell Mol Physiol 286:L834–840

    Article  PubMed  CAS  Google Scholar 

  9. Jian MY, Koizumi T, Tsushima K, Fujimoto K, Kubo K (2005) Activated protein C attenuates acid-aspiration lung injury in rats. Pulm Pharmacol Ther 18:291–296

    Article  PubMed  CAS  Google Scholar 

  10. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K (1996) Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 87:642–647

    PubMed  CAS  Google Scholar 

  11. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K (1997) Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 272:L197–202

    PubMed  CAS  Google Scholar 

  12. Sturn DH, Kaneider NC, Feistritzer C, Djanani A, Fukudome K, Wiedermann CJ (2003) Expression and function of the endothelial protein C receptor in human neutrophils. Blood 102:1499–1505

    Article  PubMed  CAS  Google Scholar 

  13. Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K, Richter D, Kast KR, Abraham E (2004) Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104:3878–3885

    Article  PubMed  CAS  Google Scholar 

  14. Maybauer MO, Maybauer DM, Fraser JF, Traber LD, Westphal M, Enkhbaatar P, Cox RA, Huda R, Hawkins HK, Morita N, Murakami K, Mizutani A, Herndon DN, Traber DL (2006) Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis. Crit Care Med 34:2432–2438

    Article  PubMed  CAS  Google Scholar 

  15. Robriquet L, Collet F, Tournoys A, Prangere T, Neviere R, Fourrier F, Guery BP (2006) Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response. Respir Res 7:41

    Article  PubMed  Google Scholar 

  16. Tomashefski JF Jr (2000) Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 21:435–466

    Article  PubMed  Google Scholar 

  17. Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, Seeger W (2000) Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 161:454–462

    PubMed  CAS  Google Scholar 

  18. Traber DL, Herndon DN, Enkhbaatar P, Maybauer MO, Maybauer DM (2007) The pathophysiology of inhalation injury. In: Herndon DN (ed.) Total burn care. Saunders, London, pp. 248–261

    Google Scholar 

  19. Eichacker PQ, Natanson C, Danner RL (2006) Surviving sepsis – practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 355:1640–1642

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Critical Care Medicine, Innsbruck Medical University, Innsbruck, Austria

    Corinna Velik-Salchner & Volker Wenzel

  2. Department of Anesthesiology and Critical Care Medicine, University Clinic Ulm, Parkstrasse 11, 89073, Ulm, Germany

    Dirk M. Maybauer & Marc O. Maybauer

Authors
  1. Corinna Velik-Salchner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Volker Wenzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dirk M. Maybauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marc O. Maybauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc O. Maybauer.

Additional information

No author has a conflict of interest that relates to the content discussed in this manuscript.

This editorial refers to the article available at: http://dx.doi.org/10.1007/s00134-007-0782-0.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Velik-Salchner, C., Wenzel, V., Maybauer, D.M. et al. Recombinant human activated protein C in experimental models of acute lung injury: the timing is critical!. Intensive Care Med 33, 2048–2050 (2007). https://doi.org/10.1007/s00134-007-0783-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-007-0783-z

Search

Navigation